WAVE.V -- Bottoming Out Undervalued Pharma/COVID-19 PlayThe most attractive part of WAVE.V is share structure: 54M total float with 41M shares held by insiders / escrowed, leaving about 13M shares free trading. The company owns a portfolio of generic oncology drugs from which it generates over $300K of quarterly revenue. $1M in cash on hand. Based on las
−0.020CAD
−664.08 KCAD
1.25 MCAD
13.61 M
About WAVERLEY PHARMA INC
Sector
CEO
Larry Thiessen
Headquarters
Winnipeg
Website
Founded
2014
ISIN
CA94357L1058
FIGI
BBG00J37TKF7
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
WAVE.V -- Pharma company offering oncology/COVID-19 drugsBig jump in this little known Canadian pharma's stock price this morning on news of market authorization of their drugs in multiple European countries. Tiny float makes for big moves up and down. Good speculative buy on pullback in the .20s, IMO.
Waverley Pharma Announces Grant of Market Authorizat
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of WAVE is 0.035 CAD — it has increased by 40.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange WAVERLEY PHARMA INC stocks are traded under the ticker WAVE.
WAVE stock is 75.00% volatile and has beta coefficient of −2.02. Check out the list of the most volatile stocks — is WAVERLEY PHARMA INC there?
Yes, you can track WAVERLEY PHARMA INC financials in yearly and quarterly reports right on TradingView.
WAVE stock hasn't changed in a week, the last month showed zero change in price, over the last year WAVERLEY PHARMA INC has showed a 40.00% increase.
WAVE net income for the last quarter is −309.96 K CAD, while the quarter before that showed −240.96 K CAD of net income which accounts for −28.64% change. Track more WAVERLEY PHARMA INC financial stats to get the full picture.
No, WAVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, WAVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAVERLEY PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WAVERLEY PHARMA INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WAVERLEY PHARMA INC stock shows the sell signal. See more of WAVERLEY PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAVERLEY PHARMA INC EBITDA is −737.12 K CAD, and current EBITDA margin is −42.54%. See more stats in WAVERLEY PHARMA INC financial statements.